Researchers and clinicians from the University of Queensland, QIMR Berghofer Medical Research Institute and Metro North Mental Health, are currently conducting a survey on knowledge, attitudes, and readiness for psychedelic-assisted therapy by GPs, psychologists, and psychiatrists
You are invited to participate in the research study ‘Improving medication adherence to reduce asthma exacerbations in children aged 5-9 years’.
The PHN is informing primary care providers that on 24/11/2023, the Public Health and Surveillance Branch in the Office of Health Protection of the Department of Health and Aged Care has issued a quarantine notice for the product; InterPharma Sodium Chloride 0.9% 10ml or 30ml ampoules.
Changes to ATAGI guidelines: Monovalent COVID-19 vaccines - As our regions faces increasing numbers of COVID-19 cases, the Australian Technical Advisory Group on Immunisation (ATAGI) has issued updated advice regarding the use of Monovalent Omicron XBB.1.5 COVID-19 vaccines.
From 1 November 2023, the varicella virus recombinant vaccine, Shingrix ®, replaces Zostavax®, on the National Immunisation Program (NIP) schedule for the prevention of shingles and post-herpetic neuralgia. It is available for eligible people most at risk of complications from shingles (1). The program changes follow recommendations from the Pharmaceutical Benefits Advisory Committee, the Australian Technical Advisory Group on Immunisation (ATAGI) and other clinical experts (1).
PHN is funding 100 one-year-licenses for the RACGP accredited ERPT tool
This research aims to identify and explore the knowledge, attitudes, and practices of young people (16-24 years) in relation to their knowledge, access, and usage of PrEP, along with the attitudes and experience of Healthcare and service providers who provide and recommend PrEP to young people in Australia.
SafeScript NSW’s new approval management functionality will mean that prescribers (medical, nurse and dental practitioners) will be able to apply online for approval to prescribe or supply certain Schedule 8 medicines (in some cases, be issued approvals in real time), monitor application progress, view patient approval (previously referred to as an authority) history, have visibility of the number of active approvals held and see all approvals held within their organisations.
The NSW Ministry of Health has updated the requirements to prescribe Schedule 8 psychostimulant medicines (dexamfetamine, lisdexamfetamine and methylphenidate). These changes recognise the scope of practice and expertise of psychiatrists, paediatricians and neurologists and are intended to reduce burden on patients, carers and families.
The research team at Monash University are exploring GPs views on factors that influence care for preconception women living with overweight or obesity.